Karacin, C. Et Al. 2021. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. FUTURE ONCOLOGY , vol.17, no.33 , 4447-4456.

Karacin, C., Eren, T., Zeynelgil, E., Imamoglu, G. I., Altinbas, M., Karadag, I., ... Basal, F. B.(2021). Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. FUTURE ONCOLOGY , vol.17, no.33, 4447-4456.

Karacin, Cengiz Et Al. "Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy," FUTURE ONCOLOGY , vol.17, no.33, 4447-4456, 2021

Karacin, Cengiz Et Al. "Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy." FUTURE ONCOLOGY , vol.17, no.33, pp.4447-4456, 2021

Karacin, C. Et Al. (2021) . "Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy." FUTURE ONCOLOGY , vol.17, no.33, pp.4447-4456.

@article{article, author={Cengiz Karacin Et Al. }, title={Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy}, journal={FUTURE ONCOLOGY}, year=2021, pages={4447-4456} }